People | Page 445 of 525 | SpiritIndia.com

Cancer :: The leukemia & lymphoma society launches program to ease the return to school for children with cancer

Each year approximately 9,000 children and teenagers are diagnosed with cancer in the United States, with leukemia representing more than 30% of these cases. Thanks to research advances, the survival rate for the most common pediatric cancer, acute lymphocytic leukemia (ALL), has improved from a dismal 4 percent in the 1960s to more than 85 percent today. However, for children who survive cancer, the challenges continue long after the treatments are over.

Multiple Sclerosis :: Treatment of relapsing-remitting multiple sclerosis

UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced a global collaboration to jointly develop and commercialize CDP323 for the treatment of relapsing-remitting multiple sclerosis (MS) and other potential indications. CDP323 is an orally active small molecule alpha4-integrin inhibitor expected to enter Phase II clinical trials next year.

Sleep :: Australasian sleep association, Perth – conference highlights

Snorers Cause Bed Partners to have EEG Arousals (91)Sean Tolhurst, University of Queensland and SNORE Australia – A new study has found that people with sleep apnea cause their bed-partners to have EEG arousals and sleep disturbance. Up until now there has been limited scientific information into how much a patient with Obstructive Sleep Apnea disturbs a sleeping bed partner. This study investigated the impact that snoring and sleep apnea events have on the bed-partner.

Health :: Testing athletes’ hearts saves lives – heart screening

If athletes’ hearts are tested the number of sudden cardiac deaths related to sports can go down significantly, say researchers from the University of Padua Medical School, Italy. For the last 24 years, all athletes in Italy have had to undergo an electrocardiogram (EKG) test before engaging in competitive sports. Approximately 2% of people tested were found to have hidden heart problems and are kept from taking part in competitive sports.

Stress :: Black tea soothes stress

Daily cups of tea can help you recover more quickly from the stresses of everyday life, according to a new study by UCL (University College London) researchers. New scientific evidence shows that black tea has an effect on stress hormone levels in the body.

Health :: Prevention and treatment are leading contributors to mental health crisis

One in four U.S. adults suffer from a diagnosable mental disorder, yet they face barriers to equal access to treatment and preventive health services, public health experts said today at a forum releasing new research examining the impact of mental illness on the nation’s health from the October 2006 issue of the American Journal of Public Health.

Lung cancer :: New cancer drug AS1404 Antisoma extends life for lung cancer patients

Lung cancer patients treated with an experimental new drug lived over a third longer than patients treated with standard chemotherapy, according to data released. The phase II study, carried out by UK biotech company Antisoma plc, looked at 70 patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer.

Diabetes :: VeraLight outperforms fasting plasma glucose for diabetes screening

Researchers will report results of a follow-on study of the first non-invasive, diabetes-screening device that was able to significantly outperform the fasting plasma glucose (FPG) test and the A1C test for identifying diabetes and pre-diabetes in individuals with one or more known risk factors for the disease. Presented at the 2006 Scientific Assembly of the American Academy of Family Physicians, held here, the study showed a prototype of the device was able to identify 29% more patients than the FPG test and 17% more patients than the A1C test. Both the FPG and A1C are blood tests used to screen and evaluate patients at risk for diabetes.

Multiple Sclerosis :: Fty720 – fingolimod reduces multiple sclerosis symptoms

The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.

Health :: Antibiotic Ceftobiprole shows promise against MRSA infections

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. today announced that ceftobiprole, a novel cephalosporin(1) antibiotic in Phase III clinical trials, was found to be active against complicated skin infections caused by common, potentially deadly bacteria, including MRSA. These data were from two poster presentations given at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). These data also were highlighted by ICAAC. Ceftobiprole is being co-developed with Basilea Pharmaceutica, Ltd. through an exclusive worldwide collaboration.